Company Overview of Zirus, Inc.
Zirus, Inc. provides a platform of host targets and a process for finding additional targets and drugs to treat commercially relevant, pandemic, neglected disease, or bioterrorist-designed viruses. The company offers Zirus Gene Trap, an antiviral host target discovery platform for the discovery of human host gene targets essential for viral replication, as well as drugs to block viral infection. Its platform is used for the development of antiviral products, drugs, and therapies. The company was incorporated in 2007 and is based in Buford, Georgia.
1384 Buford Business Boulevard
Buford, GA 30518
Founded in 2007
Key Executives for Zirus, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Zirus, Inc., please visit www.zirus.net. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.